TipRanks
Advertisement
Advertisement

NWPHF Stock Latest News

Newron presses on with Evenamide Phase 3 as FDA halts U.S. arm over safety signal
Company AnnouncementsNewron presses on with Evenamide Phase 3 as FDA halts U.S. arm over safety signal
3d ago
Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review
PremiumCompany Announcements
Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review
3d ago
Newron Pharma price target lowered to CHF 19 from CHF 35 at Roth Capital
PremiumThe Fly
Newron Pharma price target lowered to CHF 19 from CHF 35 at Roth Capital
6d ago
Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial
PremiumCompany Announcements
Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial
15d ago
Newron Bolsters Finances as Evenamide Phase 3 Program Advances Toward 2027 Readouts
PremiumCompany Announcements
Newron Bolsters Finances as Evenamide Phase 3 Program Advances Toward 2027 Readouts
19d ago
Newron Ramps Up Evenamide Phase 3 as Financing and Patent Wins Offset Wider Loss
PremiumCompany AnnouncementsNewron Ramps Up Evenamide Phase 3 as Financing and Patent Wins Offset Wider Loss
19d ago
Newron secures EUR 5.5 million tranche to fund Phase 3 Evenamide program
Premium
Company Announcements
Newron secures EUR 5.5 million tranche to fund Phase 3 Evenamide program
1M ago
Newron Bolsters Phase 3 Schizophrenia Program with EUR 5.5 Million Share Subscription
Premium
Company Announcements
Newron Bolsters Phase 3 Schizophrenia Program with EUR 5.5 Million Share Subscription
1M ago
Newron completes pivotal Phase 3 recruitment for Evenamide in treatment-resistant schizophrenia
PremiumCompany Announcements
Newron completes pivotal Phase 3 recruitment for Evenamide in treatment-resistant schizophrenia
1M ago
Newron Advances Pivotal Phase 3 Trial of Schizophrenia Candidate Evenamide
PremiumCompany Announcements
Newron Advances Pivotal Phase 3 Trial of Schizophrenia Candidate Evenamide
1M ago
Newron, FDA in constructive talks over U.S. trial halt for schizophrenia drug Evenamide
PremiumCompany Announcements
Newron, FDA in constructive talks over U.S. trial halt for schizophrenia drug Evenamide
3M ago
Newron Pharma price target lowered to CHF 44 from CHF 48 at H.C. Wainwright
PremiumThe Fly
Newron Pharma price target lowered to CHF 44 from CHF 48 at H.C. Wainwright
5M ago
PremiumCompany AnnouncementsFDA halts U.S. recruitment in Newron’s key schizophrenia trial after patient death
5M ago
Premium
Company Announcements
Newron Shareholders Back Board Changes at 2026 General Meeting
6M ago
Newron Pharmaceuticals’ Earnings Call Signals Pivotal Year Ahead
Premium
Company Announcements
Newron Pharmaceuticals’ Earnings Call Signals Pivotal Year Ahead
7M ago
Newron Pharma price target raised to CHF 48 from CHF 43 at H.C. Wainwright
PremiumThe Fly
Newron Pharma price target raised to CHF 48 from CHF 43 at H.C. Wainwright
7M ago
Newron bolsters finances as Evenamide enters pivotal global Phase III
PremiumCompany Announcements
Newron bolsters finances as Evenamide enters pivotal global Phase III
7M ago
Newron Fortifies Evenamide Phase III Push with Fresh Capital, Patent Win and Board Overhaul
PremiumCompany Announcements
Newron Fortifies Evenamide Phase III Push with Fresh Capital, Patent Win and Board Overhaul
7M ago
Newron to Highlight Phase III Evenamide Data at 2026 Schizophrenia Congress
PremiumCompany Announcements
Newron to Highlight Phase III Evenamide Data at 2026 Schizophrenia Congress
7M ago
Newron extends EIB loan maturities to align financing with Evenamide milestones
PremiumCompany AnnouncementsNewron extends EIB loan maturities to align financing with Evenamide milestones
7M ago
Newron refreshes board with CNS and capital markets experts ahead of AGM
Premium
Company Announcements
Newron refreshes board with CNS and capital markets experts ahead of AGM
7M ago
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug Evenamide
Premium
Company Announcements
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug Evenamide
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >